Keywords: ATC; Anatomical Therapeutic Chemical; EDW; Enterprise Data Warehouse; EHR; Electronic health record; eMAR; electronic medication administration records; ETL; extract-transform-load; IRB; Institutional Review Board; IV; intra-venous; MAR; Medication Admini
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AMD; age-related macular degeneration; CATT; Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial; CF; counting fingers; CNV; choroidal neovascularization; HARBOR; A Phase III, Double-masked, Multicenter, Randomized, Ac
Keywords: BCVA; best-corrected visual acuity; CNV; choroidal neovascularization; CRT; central retinal thickness; ERM; epiretinal membrane; nAMD; neovascular age-related macular degeneration; PRN; pro re nata; PVD; posterior vitreous detachment; SD; spectral-domain;
Keywords: BCVA; best-corrected visual acuity; CRT; central retinal thickness; DCP; deep capillary plexus; DME; diabetic macular edema; DR; diabetic retinopathy; ELM; external limiting membrane; EZ; ellipsoid zone; FAZ; foveal avascular zone; logMAR; logarithm of th
Keywords: APTC; Antiplatelet Trialists' Collaboration; ATE; arterial thromboembolic event; CBV; cerebrovascular; CI; confidence interval; CV; cardiovascular; EPAR; European Public Assessment Report; ICD-9-CM; International Classification of Diseases, Ninth Revision
Keywords: AE; adverse event; BCVA; best-corrected visual acuity; CI; confidence interval; CRC; central reading center; CSC; central serous chorioretinopathy; CSFT; central subfield thickness; CSFV; central subfield volume; DME; diabetic macular edema; ETDRS; Early
Keywords: CS2; carbon disulfide; dB(A); A-weighted decibel; LEX,8h; Equivalent continuous noise level calculated over 8 h; PCR; Polymerase chain reaction; PRN; post-rotatory nystagmus; VOR; vestibulo-ocular reflex; Carbon disulfide; Low-frequency noise; Post-rotato
Keywords: AMD; age-related macular degeneration; approxETDRS; approximate Early Treatment Diabetic Retinopathy Study; CRT; central retinal thickness; CRVO; central retinal vein occlusion; logMAR; logarithm of the minimum angle of resolution; PRN; pro re nata; PRP;
Keywords: AMD; age-related macular degeneration; anti-VEGF; anti-vascular endothelial growth factor; CNV; choroidal neovascularization; ETDRS; Early Treatment Diabetic Retinopathy Study; PRN; Pro re nata; SD; standard deviation;
Keywords: AMD; age-related macular degeneration; BCVA; best-corrected visual acuity; CRT; central retinal thickness; ETDRS; Early Treatment Diabetic Retinopathy Study; PED; pigment epithelial detachment; PRN; pro re nata; SD; spectral domain; TREX; treat and extend
Keywords: AMD; age-related macular degeneration; AREDS; Age-Related Eye Disease Study; CATT; Comparison of AMD Treatment Trials; CNV; choroidal neovascularization; FA; fluorescein angiography; FAF; fundus autofluorescence; GA; geographic atrophy; ICG; indocyanine g
Keywords: aHR; adjusted hazard ratio; AMD; age-related macular degeneration; CATT; Comparison of AMD Treatments Trials; CI; confidence interval; CNV; choroidal neovascularization; CP; color photograph; DA; disc area; FA; fluorescein angiography; GA; geographic atro
Keywords: AE; adverse event; BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CI; confidence interval; CRC; Central Reading Center; CSFT; central subfield thickness; ETDRS; Early Treatment Diabetic Retinopathy Study; LS; least squares; OCT;
Keywords: AV; arteriovenous; BCVA; best-corrected visual acuity; BRAVO; RanibizumaB for the treatment of macular edema following bRAnch retinal Vein Occlusion; BRVO; branch retinal vein occlusion; BVOS; Branch Vein Occlusion Study; CFT; central foveal thickness; CP
Keywords: Infant innate immunity; Low vaccine response; IRF7; IFN-α; IL12p70; RANTES; APC; antigen presenting cell; cDC; conventional DC; DT; diphtheria toxoid; FBS; fetal bovine serum; FHA; filamentous haemagglutinin; IRF; IFN response factors; LVR; low vaccine r
Keywords: AsF; asialofetuin; BSA; bovine serum albumin; D; diphtheria toxoid; EDTA; ethylene diamine tetra-acetic acid; Fet; fetuin; FHA; filamentous haemagglutinin; Fims2/3; fimbriae type 2 and type 3; F; formaldehyde; g-PTd; genetically inactivated PTx toxoid; G;
Keywords: CATT; Comparison of Age-related Macular Degeneration Treatments Trials; CME; cystoid macular edema; CNV; choroidal neovascularization; CRT; central retinal thickness; FA; fluorescein angiography; IRF; intraretinal fluid; nAMD; neovascular age-related macu
Keywords: JE; Japanese encephalitis; PRN; plaque reduction neutralization; ELISA; enzyme-linked immunosorbent assay; CEC; chick embryo cell; EMEM; Eagle's minimum essential medium; CV; coefficient of variation; Japanese encephalitis vaccines; in vivo; in vitro; ELI
Keywords: DTaP; Polio; Hib; Hepatitis B; Hexavalent; Vaccine; Safety; Immunogenicity; AE; adverse event(s); CI; confidence interval; D; diphtheria toxoid; DTaP5; diphtheria, tetanus, acellular pertussis (5-component) vaccine (Daptacelâ¢); DTPa3-HB-IPV/Hib; diphthe
Keywords: DCE; discrete choice experiment; logMAR; logarithm of the minimum angle of resolution; nAMD; neovascular age-related macular degeneration; PRN; pro re nata; VA; visual acuity; VEGF; vascular endothelial growth factor;
Keywords: AMD; age-related macular degeneration; BCVA; best-corrected visual acuity; CRT; central retinal thickness; ETDRS; Early Treatment Diabetic Retinopathy Study; OCT; optical coherence tomography; PCV; polypoidal choroidal vasculopathy; PED; pigment epithelia
Keywords: AMD; age-related macular degeneration; CATT; Comparison of Age-Related Macular Degeneration Treatments Trials; CI; confidence interval; CNV; choroidal neovascularization; CVD; cardiovascular disease; DA; disc area; OR; odds ratio; PRN; pro re nata;
Keywords: ANCOVA; analysis of covariance; BCVA; best-corrected visual acuity; CI; confidence interval; CNV; choroidal neovascularization; IRC; intraretinal cystoid fluid; nAMD; neovascular age-related macular degeneration; OCT; optical coherence tomography; PED; pi
Keywords: CI; confidence interval; CNV; choroidal neovascular membrane; FRB; Fight Retinal Blindness; IQR; interquartile range; LOCF; last observation carried forward; nAMD; neovascular age-related macular degeneration; PRN; pro re nata; RCT; randomized controlled
Keywords: BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CRVO; central retinal vein occlusion; DME; diabetic macular edema; HARBOR; Phase III, Double-Masked, Multicenter, Randomized, Active Treatment-Controlled Study of the Efficacy and Sa
Keywords: BRVO; branch retinal vein occlusion; CRVO; central retinal vein occlusion; PRN; pro re nata; RELATE; Ranibizumab Dose Comparison (0.5 mg and 2.0 mg) and the Role of Laser in the Management of Retinal Vein Occlusion; RNP; retinal nonperfusion; RVO; retinal
Keywords: ADF; Acid detergent fibre; ADL; Acid detergent liquid; ATR; Attenuated total reflectance; CZM; Cohesive zone model; CW; Cell wall; FTIR; Fourier Transform infrared; NDF; Neutral detergent fibre; OPEFB; Oil palm empty fruit bunch; PRN; Parallel rheological
Keywords: AMD; age-related macular degeneration; ANCHOR; Anti-VEGF Antibody Fragment Ranibizumab for the Treatment of Predominantly Classic Choroidal Neovascularization in AMD; CI; confidence interval; GA; geographic atrophy; HORIZON; An Open-Label, Multicenter Ext
Keywords: BPD; Bronchopulmonary dysplasia; NICHD; Eunice Kennedy Shriver National Institute of Child Health and Human Development; NICU; Neonatal intensive care unit; PMA; Postmenstrual age; PRN; National Perinatal Registry; VON; Vermont Oxford Network;
Keywords: AlOH; aluminum hydroxide; aP; acellular pertussis; AUC; area under the clearance curve; B. pertussis; Bordetella pertussis; CFU; colony-forming units; DTaP-IPV; diphtheria-tetanus-acellular pertussis and poliomyelitis; EDS; epicutaneous delivery system; E
Keywords: AMD; age-related macular degeneration; CATT; Comparison of Age-related Macular Degeneration Treatments Trials; CI; confidence interval; CNV; choroidal neovascularization; FA; fluorescein angiography; GA; geographic atrophy; OCT; optical coherence tomograp
Keywords: CI; confidence interval; NICU; neonatal intensive care; PCG; Perinatal Co-operation Group; PRN; National Perinatal Register (Netherlands); RR; relative risk; Midwifery; Perinatal mortality; Intrapartum mortality; Neonatal mortality; Home birth;
Keywords: AMD; age-related macular degeneration; FRB; Fight Retinal Blindness; logMAR; logarithm of the minimum angle of resolution; PRN; pro re nata; SD; standard deviation; VA; visual acuity; VEGF; vascular endothelial growth factor;
Keywords: AE; adverse event; BCVA; best-corrected visual acuity; CI; confidence interval; CRT; central retinal thickness; DME; diabetic macular edema; ETDRS; Early Treatment Diabetic Retinopathy Study; FAS; full analysis set; PRN; pro re nata; RELIGHT; Ranibizumab
Keywords: Booster; Vaccine; Immunogenicity; Safety; Tdpa; acellular pertussis vaccine; Antibody persistence; Aluminium; AE; adverse event; ATP; according to protocol; BR; booster response; CI; confidence interval; DT; diphtheria toxoid; dTpa; reduced antigen conten
Keywords: AMD; age-related macular degeneration; BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CRVO; central retinal vein occlusion; CST; central subfield thickness; OCT; optical coherence tomography; PRN; pro re nata; RBZ; ranibizumab; R
Keywords: AMD; age-related macular degeneration; CATT; Comparison of Age-Related Macular Degeneration Treatments Trials; CFP; color fundus photographs; CNV; choroidal neovascularization; ELM; external limiting membrane; EZ; ellipsoid zone; FA; fluorescein angiograp
Keywords: AD; anaerobic digestion; BD; biodegradable; BG; brown glass; BMT; biological-mechanical treatment; CG; clear glass; Defra; Department for Environment, Food and Rural Affairs; ELfD; European Landfill Directive; FM; ferrous metal; GBSC; non-recyclable gla
Keywords: Amantadine; Antidepressive agents; Antipsychotic agents; Brain injuries; Central nervous system stimulants; Drug therapy; Medication therapy management; Patient care; Physician's practice patterns; Polypharmacy; Rehabilitation; AChEI; acetylcholinesterase
Keywords: ASCT; autologous stem cell transplant; Edm; Edmonston; FDG; fluorodeoxyglucose; GFP; green fluorescent protein; M-protein; monoclonal protein; MM; multiple myeloma; MV; measles virus; MV-NIS; measles virus encoding human sodium iodide symporter; NIS; sodi
Keywords: TC; Thyroid cancer; NMTC; Nonmedullary thyroid cancer; PTC; Papillary thyroid cancer; FTC; Follicular thyroid cancer; HTC; Hürthle cell thyroid cancer; ATC; Anaplastic thyroid cancer; FAP; Adenomatous polyposis of colon; FNAC; Fine-needle aspiration cyto
Keywords: Vaccination; Neonate; Infants; Children; B cells; T cells; Antigen presenting cells; Dendritic cells; immunologic memory; pediatric vaccines; Streptococcus pneumoniae; Haemophilus influenzae; B-cell receptor; MHC II; CD4 T-cells; cytokines; T-cell recepto
Keywords: Evaluation studies; Clinical trials; Workflow; Needs assessment; Medical informatics; IMPACT; Integrated Model for Patient Care and Clinical Trials; CRC; Clinical Research Coordinator; CTMS; Clinical Trial Management System; SUS; System Usability Scale; U
Keywords: AE; adverse event; BCVA; best-corrected visual acuity; BRAVO; Treatment of Macular Edema following Branch Retinal Vein Occlusion: Evaluation of Efficacy and Safety; BRVO; branch retinal vein occlusion; CRUISE; Treatment of Macular Edema following Central
Keywords: AMD; age-related macular degeneration; ATE; arterial thromboembolic event; CVA; cerebrovascular accident; FDA; US Food and Drug Administration; MedDRA; Medical Dictionary for Regulatory Activities; MI; myocardial infarction; OR; odds ratio; PDT; photodyna
Keywords: A1; auditory cortex; CC; corpus callosum; CP; cortical plate; CPN; callosal projection neurons; CSMN; corticospinal motor neurons; CST; corticospinal tract; CTA; corticothalamic axons; Ctip2; COUP-TF interacting protein 2; DCC; deleted in colorectal carci
An ELISA method to estimate the mono ADP-ribosyltransferase activities: e.g in pertussis toxin and vaccines
Keywords: Mono ADP-Ribosyltransferase; Macro domain; Pertussis toxin; Pertussis vaccines; Enzyme-ELISA; ADP; Adenosine diphosphate; ABTS; 2,2â²-Azino-bis (3-ethylbenzothiazoline-6-sulphonic acid); BSA; bovine serum albumin; D; diphtheria toxoid; ELISA; Enzyme-link
Aflibercept for Previously Treated Macular Edema Associated with Central Retinal Vein Occlusions: 1-Year Results of the NEWTON Study
Keywords: BCVA; best-corrected visual acuity; CME; cystoid macular edema; CRVO; central retinal vein occlusion; CST; central subfoveal retinal thickness; ETDRS; Early Treatment Diabetic Retinopathy Study; IAI; intravitreal aflibercept injection; PRN; pro re nata; S
Baseline Predictors for Five-Year Visual Acuity Outcomes in the Comparison of AMD Treatment Trials
Keywords: AMD; age-related macular degeneration; CATT; Comparison of AMD Treatments Trials; CNV; choroidal neovascularization; OR; odds ratio; PRN; pro re nata; RPE; retinal pigment epithelium; SNP; single nucleotide polymorphism; VA; visual acuity; VEGF; vascular
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vacci
Keywords: AE; adverse event; ap; acellular pertussis; ATP; according to protocol; CI; confidence interval; d; diphtheria (low dose); D; diphtheria, (high dose); dTap-IPV; reduced antigen diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine; ELISA;